The European Commission’s Joint Research Centre (JRC) has released a new certified reference material (CRM) for the enzyme aspartate transaminase (AST).
Elevated levels of AST in blood tests are associated with several liver disorders, (including hepatitis, fatty liver disease and liver cancer) which are a significant public health concern affecting millions of people worldwide.
Early detection and accurate diagnosis are critical for effective treatment and improving patient outcomes.
By providing a CRM for AST, the JRC is helping to improve the accuracy and reliability of liver disease diagnosis, ultimately leading to better patient outcomes.
A new certified reference material developed by the JRC